Moleculin Biotech Reports Second Quarter 2026 Financial Results and Highlights Continued Advancement of Pivotal MIRACLE Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. SPY
2. USO
3. IONQ
4. IONS
5. AAPL
6. HOOD
7. QCOM
8. ACN
9. AZN
10. ROIV

Go back to Moleculin Biotech Reports Second Quarter 2026 Financial Results and Highlights Continued Advancement of Pivotal MIRACLE Trial
METABASIS THERAPEUT (NASDAQ: MBRX) Delayed: 0.75 +0.04 (5.63%)
Previous Close $0.71    52 Week High $9.58 
Open $0.74    52 Week Low $2.34 
Day High $0.80    P/E N/A 
Day Low $0.72    EPS $-0.34 
Volume 736,206